Community/Retail

A new 200-units/mL formulation of Lilly's pre-filled insulin pen containing rapid-acting insulin lispro is now available at pharmacies for patients with diabetes.

Up to 82% of patients with headaches turn to complementary and alternative medicine for relief, frequently without first consulting a physician.

Students in East Tennessee State University's Bill Gatton College of Pharmacy will have the opportunity to earn a bachelor's degree while studying for the Doctor of Pharmacy degree starting this fall.

Rupal Mansukhani, PharmD, clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, gives advice for pharmacists on how to prepare for this next flu season.

Mylan N.V. today clarified certain inaccuracies by third parties related to Mylan having lowered the acceptance condition in its offer to acquire Perrigo Company plc from not less than 80% of Perrigo ordinary shares to greater than 50% of Perrigo ordinary share.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses medication errors involving insulin.

The FDA is considering expanding the use of Merck's pembrolizumab as a first-line treatment for advanced melanoma.

Those big, white coolers filled with flu vaccines are about to come rolling into the pharmacy.

Erin Dorval, PharmD, community assistant professor of pharmacy practice at Palm Beach Atlantic University, talks about the differences in counseling points, depending on the type of URTI.

If a company as large as Walmart has no bargaining power with pharmacy benefit managers, as a Morningstar analyst suggests, then it's no wonder why independent community pharmacists complain about PBMs.

New licensing agreement permits RTP Company to produce and sell Radel R-7000 PPSU resins, offering shorter lead times and more flexibility for customer orders.

Valeant Pharmaceuticals International, Inc. and Sprout Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a wholly-owned subsidiary of Valeant will acquire Sprout.

A recent survey shows pharmacists provide consultations to customers more than 12 times per week and about 90% of those consultations include OTC discussions.

Pharmacists should not use compounded drugs stored in 3-mL and 5-mL syringes from Becton-Dickinson unless no suitable alternatives are available, the FDA warns.

Bystanders who initiate cardiopulmonary resuscitation improve survival and neurological outcomes for patients experiencing out-of-hospital cardiac arrest.

The start of the new school year brings a multitude of questions from parents and caregivers about children's vaccination requirements, so pharmacists need to be prepared with answers.

Walgreens and Providence Health & Services have announced a strategic clinical collaboration aimed at coordinating patient care and improving patient access, which plans to bring up to 25 new retail clinics to Oregon and Washington.

A pharmacist's swift action saved a woman's life during an emergency situation.

In the long wake of a deadly meningitis outbreak from tainted drugs distributed by a compounding pharmacy in Massachusetts, state regulators have been increasing their inspections of pharmacies with complaints.

A group of 4 students from the University of Arkansas for Medical Sciences College of Pharmacy have been named finalists in the Good Neighbor Pharmacy National Community Pharmacists Association Pruitt-Schutte Student Business Plan Competition.

Patients with any type of health insurance receive preventive care for chronic diseases at rates up to 3 times higher than their uninsured counterparts, the US Centers for Disease Control and Prevention has found.

Mary Jo Goolsby, EdD, MSN, NP-C, FAANP, FAAN, owner of the Institute for NP Excellence, discusses how DOT Medical Examiners can improve patients' health.

Equashield reported a 106% increase in sales, with the upward financial growth capping off a twelve-month period of rapid expansion for the CSTD manufacturer.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses counseling points for patients taking oral non-insulin diabetes medication.

The FDA has expanded the use of Raptor Pharmaceutical's cysteamine bitartrate delayed-release capsules to treat nephropathic cystinosis in children ages 2 to 6.

Roche today announced that it has signed a definitive agreement to acquire Kapa Biosystems, Inc., a privately-held company that is a provider of genomic tools in the life sciences sector.

The FDA has approved flibanserin (Addyi), the first drug to treat generalized hypoactive sexual desire disorder in premenopausal women.